Eurocept invests in the development of medicines for rare metabolic diseases by acquisition of the French company Lucane Pharma SA

Eurocept invests in the development of medicines for rare metabolic diseases by acquisition of the French company Lucane Pharma SA Ankeveen, 20th October 2017 Eurocept Pharmaceuticals announces that it acquired the Paris based company Lucane Pharma SA, effective…

Lees meer